These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Davidson M, Ma P, Stein EA, Gotto AM, Raza A, Chitra R, Hutchinson H. Am J Cardiol; 2002 Feb 01; 89(3):268-75. PubMed ID: 11809427 [Abstract] [Full Text] [Related]
6. Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study. Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F, POLARIS study investigators. Atherosclerosis; 2007 Oct 01; 194(2):e154-64. PubMed ID: 17229426 [Abstract] [Full Text] [Related]
7. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. Faergeman O, Hill L, Windler E, Wiklund O, Asmar R, Duffield E, Sosef F, ECLIPSE Study Investigators. Cardiology; 2008 Oct 01; 111(4):219-28. PubMed ID: 18434729 [Abstract] [Full Text] [Related]
8. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep 01; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]
13. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. Ballantyne CM, Raichlen JS, Cain VA. J Am Coll Cardiol; 2008 Aug 19; 52(8):626-32. PubMed ID: 18702965 [Abstract] [Full Text] [Related]
15. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group. Clin Ther; 2004 Nov 19; 26(11):1821-33. PubMed ID: 15639694 [Abstract] [Full Text] [Related]
16. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, Wiklund O, Southworth H, Pears J, Wilpshaar JW, Rosuvastatin Investigators Group. Am Heart J; 2002 Dec 19; 144(6):1044-51. PubMed ID: 12486429 [Abstract] [Full Text] [Related]
20. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH. Clin Ther; 2007 Nov 19; 29(11):2385-94. PubMed ID: 18158079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]